June 19, 2017 / 11:21 AM / 5 months ago

BRIEF-FDA grants fast track designation to Axovant's nelotanserin

June 19 (Reuters) - Axovant Sciences Ltd

* FDA grants fast track designation to Axovant’s nelotanserin for visual hallucinations in dementia with lewy bodies

* Axovant Sciences - FDA granted fast track designation to investigational drug nelotanserin for treatment of visual hallucinations disorder in dementia with lewy bodies Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below